Schaap FG

References (2)

Title : Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding - Dorfmeister_2008_Arterioscler.Thromb.Vasc.Biol_28_1866
Author(s) : Dorfmeister B , Zeng WW , Dichlberger A , Nilsson SK , Schaap FG , Hubacek JA , Merkel M , Cooper JA , Lookene A , Putt W , Whittall R , Lee PJ , Lins L , Delsaux N , Nierman M , Kuivenhoven JA , Kastelein JJ , Vrablik M , Olivecrona G , Schneider WJ , Heeren J , Humphries SE , Talmud PJ
Ref : Arterioscler Thromb Vasc Biol , 28 :1866 , 2008
Abstract : Dorfmeister_2008_Arterioscler.Thromb.Vasc.Biol_28_1866
ESTHER : Dorfmeister_2008_Arterioscler.Thromb.Vasc.Biol_28_1866
PubMedSearch : Dorfmeister_2008_Arterioscler.Thromb.Vasc.Biol_28_1866
PubMedID: 18635818

Title : ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis - Schaap_2004_J.Biol.Chem_279_27941
Author(s) : Schaap FG , Rensen PC , Voshol PJ , Vrins C , van der Vliet HN , Chamuleau RA , Havekes LM , Groen AK , van Dijk KW
Ref : Journal of Biological Chemistry , 279 :27941 , 2004
Abstract : Schaap_2004_J.Biol.Chem_279_27941
ESTHER : Schaap_2004_J.Biol.Chem_279_27941
PubMedSearch : Schaap_2004_J.Biol.Chem_279_27941
PubMedID: 15090553